Summary

Advanced Therapy Medicinal Products Market – Scope of Report
TMR’s report on the global advanced therapy medicinal productss market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global advanced therapy medicinal productss market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global advanced therapy medicinal productss market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the advanced therapy medicinal productss market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global advanced therapy medicinal productss market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global advanced therapy medicinal productss market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global advanced therapy medicinal productss market.

The report delves into the competitive landscape of the global advanced therapy medicinal productss market. Key players operating in the global advanced therapy medicinal productss market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global advanced therapy medicinal productss market profiled in this report.

Key Questions Answered in Global advanced therapy medicinal productss Market Report
• What is the sales/revenue generated by advanced therapy medicinal productss across all regions during the forecast period?
• What are the opportunities in the global advanced therapy medicinal productss market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Advanced Therapy Medicinal Products Market – Research Objectives and Research Approach
The comprehensive report on the global advanced therapy medicinal productss market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global advanced therapy medicinal productss market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global advanced therapy medicinal productss market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Advanced Therapy Medicinal Products Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Reimbursement Scenario
5.4. Mergers, Acquisition, Partnership, and Collaboration Scenario
5.5. COVID-19 Pandemic Impact Analysis
6. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Therapy Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Therapy Type, 2020-2034
6.3.1. Cell Therapy
6.3.2. Gene Therapy
6.3.3. Tissue Engineering
6.4. Market Attractiveness By Therapy Type
7. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2020-2034
7.3.1. Oncology
7.3.2. Neurology
7.3.3. Cardiology
7.3.4. Dermatology
7.3.5. Infectious Diseases
7.3.6. Musculoskeletal Disorders
7.3.7. Orthopedics
7.3.8. Others (Genetic Disorders, etc.)
7.4. Market Attractiveness By Indication
8. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Advanced Therapy Medicinal Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Therapy Type, 2020-2034
10.2.1. Cell Therapy
10.2.2. Gene Therapy
10.2.3. Tissue Engineering
10.3. Market Value Forecast By Indication, 2020-2034
10.3.1. Oncology
10.3.2. Neurology
10.3.3. Cardiology
10.3.4. Dermatology
10.3.5. Infectious Diseases
10.3.6. Musculoskeletal Disorders
10.3.7. Orthopedics
10.3.8. Others (Genetic Disorders, etc.)
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Therapy Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Advanced Therapy Medicinal Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Therapy Type, 2020-2034
11.2.1. Cell Therapy
11.2.2. Gene Therapy
11.2.3. Tissue Engineering
11.3. Market Value Forecast By Indication, 2020-2034
11.3.1. Oncology
11.3.2. Neurology
11.3.3. Cardiology
11.3.4. Dermatology
11.3.5. Infectious Diseases
11.3.6. Musculoskeletal Disorders
11.3.7. Orthopedics
11.3.8. Others (Genetic Disorders, etc.)
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Market Value Forecast By Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Therapy Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Advanced Therapy Medicinal Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Therapy Type, 2020-2034
12.2.1. Cell Therapy
12.2.2. Gene Therapy
12.2.3. Tissue Engineering
12.3. Market Value Forecast By Indication, 2020-2034
12.3.1. Oncology
12.3.2. Neurology
12.3.3. Cardiology
12.3.4. Dermatology
12.3.5. Infectious Diseases
12.3.6. Musculoskeletal Disorders
12.3.7. Orthopedics
12.3.8. Others (Genetic Disorders, etc.)
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Market Value Forecast By Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Therapy Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Advanced Therapy Medicinal Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Therapy Type, 2020-2034
13.2.1. Cell Therapy
13.2.2. Gene Therapy
13.2.3. Tissue Engineering
13.3. Market Value Forecast By Indication, 2020-2034
13.3.1. Oncology
13.3.2. Neurology
13.3.3. Cardiology
13.3.4. Dermatology
13.3.5. Infectious Diseases
13.3.6. Musculoskeletal Disorders
13.3.7. Orthopedics
13.3.8. Others (Genetic Disorders, etc.)
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Market Value Forecast By Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Therapy Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Advanced Therapy Medicinal Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Therapy Type, 2020-2034
14.2.1. Cell Therapy
14.2.2. Gene Therapy
14.2.3. Tissue Engineering
14.3. Market Value Forecast By Indication, 2020-2034
14.3.1. Oncology
14.3.2. Neurology
14.3.3. Cardiology
14.3.4. Dermatology
14.3.5. Infectious Diseases
14.3.6. Musculoskeletal Disorders
14.3.7. Orthopedics
14.3.8. Others (Genetic Disorders, etc.)
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Market Value Forecast By Country/Sub-region, 2020-2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Therapy Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Competitive Dashboard
15.3.1. By Region
15.3.2. By Therapy Type
15.4. Company Profiles
15.4.1. Spark Therapeutics, Inc.
15.4.1.1. Company Overview
15.4.1.2. Financial Overview
15.4.1.3. Product Portfolio
15.4.1.4. Business Strategies
15.4.1.5. Recent Developments
15.4.2. Bluebird Bio, Inc.
15.4.2.1. Company Overview
15.4.2.2. Financial Overview
15.4.2.3. Product Portfolio
15.4.2.4. Business Strategies
15.4.2.5. Recent Developments
15.4.3. Novartis AG.
15.4.3.1. Company Overview
15.4.3.2. Financial Overview
15.4.3.3. Product Portfolio
15.4.3.4. Business Strategies
15.4.3.5. Recent Developments
15.4.4. UniQure N.V.
15.4.4.1. Company Overview
15.4.4.2. Financial Overview
15.4.4.3. Product Portfolio
15.4.4.4. Business Strategies
15.4.4.5. Recent Developments
15.4.5. MEDIPOST
15.4.5.1. Company Overview
15.4.5.2. Financial Overview
15.4.5.3. Product Portfolio
15.4.5.4. Business Strategies
15.4.5.5. Recent Developments
15.4.6. Vericel Corporation
15.4.6.1. Company Overview
15.4.6.2. Financial Overview
15.4.6.3. Product Portfolio
15.4.6.4. Business Strategies
15.4.6.5. Recent Developments
15.4.7. PHARMICELL Co., Ltd
15.4.7.1. Company Overview
15.4.7.2. Financial Overview
15.4.7.3. Product Portfolio
15.4.7.4. Business Strategies
15.4.7.5. Recent Developments
15.4.8. Organogenesis Inc.
15.4.8.1. Company Overview
15.4.8.2. Financial Overview
15.4.8.3. Product Portfolio
15.4.8.4. Business Strategies
15.4.8.5. Recent Developments
15.4.9. Others Prominent Players
15.4.9.1. Company Overview
15.4.9.2. Financial Overview
15.4.9.3. Product Portfolio
15.4.9.4. Business Strategies
15.4.9.5. Recent Developments